BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12606510)

  • 1. Gene expression profiles of nondiabetic and diabetic obese mice suggest a role of hepatic lipogenic capacity in diabetes susceptibility.
    Lan H; Rabaglia ME; Stoehr JP; Nadler ST; Schueler KL; Zou F; Yandell BS; Attie AD
    Diabetes; 2003 Mar; 52(3):688-700. PubMed ID: 12606510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice.
    Haluzik M; Colombo C; Gavrilova O; Chua S; Wolf N; Chen M; Stannard B; Dietz KR; Le Roith D; Reitman ML
    Endocrinology; 2004 Jul; 145(7):3258-64. PubMed ID: 15059949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profiling of type 2 diabetes susceptibility genes in the pancreatic islets, adipose tissue and liver of obese mice.
    Morrison F; Locke J; Arif M; Murray A; Brown JE; Harries LW
    Exp Clin Endocrinol Diabetes; 2013 Jul; 121(7):413-9. PubMed ID: 23839539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice.
    Zhao E; Keller MP; Rabaglia ME; Oler AT; Stapleton DS; Schueler KL; Neto EC; Moon JY; Wang P; Wang IM; Lum PY; Ivanovska I; Cleary M; Greenawalt D; Tsang J; Choi YJ; Kleinhanz R; Shang J; Zhou YP; Howard AD; Zhang BB; Kendziorski C; Thornberry NA; Yandell BS; Schadt EE; Attie AD
    Mamm Genome; 2009 Aug; 20(8):476-85. PubMed ID: 19727952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic obesity unmasks nonlinear interactions between murine type 2 diabetes susceptibility loci.
    Stoehr JP; Nadler ST; Schueler KL; Rabaglia ME; Yandell BS; Metz SA; Attie AD
    Diabetes; 2000 Nov; 49(11):1946-54. PubMed ID: 11078464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in type 2 diabetes--related traits in mouse strains susceptible to diet-induced obesity.
    Rossmeisl M; Rim JS; Koza RA; Kozak LP
    Diabetes; 2003 Aug; 52(8):1958-66. PubMed ID: 12882911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis.
    Massart J; Robin MA; Noury F; Fautrel A; Lettéron P; Bado A; Eliat PA; Fromenty B
    Br J Pharmacol; 2012 Mar; 165(5):1361-74. PubMed ID: 21740407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolite profiling in plasma and tissues of ob/ob and db/db mice identifies novel markers of obesity and type 2 diabetes.
    Giesbertz P; Padberg I; Rein D; Ecker J; Höfle AS; Spanier B; Daniel H
    Diabetologia; 2015 Sep; 58(9):2133-43. PubMed ID: 26058503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and genomic studies of the BTBR ob/ob mouse model of type 2 diabetes.
    Clee SM; Nadler ST; Attie AD
    Am J Ther; 2005; 12(6):491-8. PubMed ID: 16280642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The messenger RNA profiles in liver, hypothalamus, white adipose tissue, and skeletal muscle of female Zucker diabetic fatty rats after topiramate treatment.
    Liang Y; She P; Wang X; Demarest K
    Metabolism; 2006 Oct; 55(10):1411-9. PubMed ID: 16979414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus.
    Rahimian R; Masih-Khan E; Lo M; van Breemen C; McManus BM; Dubé GP
    Mol Cell Biochem; 2001 Aug; 224(1-2):29-37. PubMed ID: 11693197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice.
    Zhang B; Graziano MP; Doebber TW; Leibowitz MD; White-Carrington S; Szalkowski DM; Hey PJ; Wu M; Cullinan CA; Bailey P; Lollmann B; Frederich R; Flier JS; Strader CD; Smith RG
    J Biol Chem; 1996 Apr; 271(16):9455-9. PubMed ID: 8621615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
    Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
    Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice.
    Allen DL; Cleary AS; Speaker KJ; Lindsay SF; Uyenishi J; Reed JM; Madden MC; Mehan RS
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E918-27. PubMed ID: 18334608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased lipids in non-lipogenic tissues are indicators of the severity of type 2 diabetes in mice.
    Campbell-Tofte J; Hansen HS; Mu H; Mølgaard P
    Prostaglandins Leukot Essent Fatty Acids; 2007 Jan; 76(1):9-18. PubMed ID: 17098406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between aquaglyceroporin expression and development of fatty liver in diet-induced obesity and ob/ob mice.
    Hirako S; Wakayama Y; Kim H; Iizuka Y; Matsumoto A; Wada N; Kimura A; Okabe M; Sakagami J; Suzuki M; Takenoya F; Shioda S
    Obes Res Clin Pract; 2016; 10(6):710-718. PubMed ID: 26747210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
    Vidal-Puig A; Jimenez-Liñan M; Lowell BB; Hamann A; Hu E; Spiegelman B; Flier JS; Moller DE
    J Clin Invest; 1996 Jun; 97(11):2553-61. PubMed ID: 8647948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists.
    Scislowski PW; Tozzo E; Zhang Y; Phaneuf S; Prevelige R; Cincotta AH
    Int J Obes Relat Metab Disord; 1999 Apr; 23(4):425-31. PubMed ID: 10340822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis.
    Colombo M; Kruhoeffer M; Gregersen S; Agger A; Jeppesen P; Oerntoft T; Hermansen K
    Metabolism; 2006 Jan; 55(1):43-52. PubMed ID: 16324918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.